BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6658461)

  • 21. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New developments in laboratory diagnosis and monitoring.
    Kitchen S; Hayward C; Negrier C; Dargaud Y
    Haemophilia; 2010 Jul; 16 Suppl 5():61-6. PubMed ID: 20590858
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of automation in the development of reagents and kits for automated methods in coagulation testing.
    Martinoli JL; Amiral J
    Semin Thromb Hemost; 1983 Jul; 9(3):194-205. PubMed ID: 6351254
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
    Dorn-Beineke A; Dempfle CE; Bertsch T; Wisser H
    Thromb Res; 2005; 116(2):171-9. PubMed ID: 15907533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of comparing fibrinogen Clauss and prothrombin time derived method.
    Llamas P; Santos AB; Outeiriño J; Soto C; Tomás JF
    Thromb Res; 2004; 114(1):73-4. PubMed ID: 15262488
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
    Appert-Flory A; Fischer F; Jambou D; Toulon P
    Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Clin Chem; 1983 Feb; 29(2):225-36. PubMed ID: 6821923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.
    Latallo ZS; Thomson JM; Poller L
    Br J Haematol; 1981 Feb; 47(2):307-18. PubMed ID: 7470395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation testing with the Du Pont aca discrete clinical analyzer.
    Pierson-Perry JF; Wehrly JA; Siefring GE
    Semin Thromb Hemost; 1983 Oct; 9(4):321-33. PubMed ID: 6658463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibilities of error and their elimination in blood coagulation studies].
    Weiss W
    Z Arztl Fortbild (Jena); 1977 Jul; 71(13):613-5. PubMed ID: 556496
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of an automated analyzer in the evaluation of antithrombin III and heparin.
    Scully MF
    Semin Thromb Hemost; 1983 Oct; 9(4):309-20. PubMed ID: 6658462
    [No Abstract]   [Full Text] [Related]  

  • 33. [Round table on the use of chromogenic substrates in hemostasiologic diagnosis].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):189-200. PubMed ID: 6177604
    [No Abstract]   [Full Text] [Related]  

  • 34. Monocyte procoagulant activity: development of a microtitre plate chromogenic assay.
    Baker P; Joshi M; Luddington R
    Br J Biomed Sci; 1994 Dec; 51(4):328-31. PubMed ID: 7756938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood coagulation diagnostic in the neonatal period using chromogenic peptides].
    Göbel U; Jürgens H; von Kries R; Wahn V; von Voss H
    Med Lab (Stuttg); 1980 Nov; 33(11):297-303. PubMed ID: 7464648
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the automated coagulation analyser ACL TOP (instrumentation laboratory)].
    Eschwège V; Catillon C; Robert A
    Ann Biol Clin (Paris); 2006; 64(3):259-64. PubMed ID: 16698562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of methods of freezing and thawing of blood plasma on the activity of procoagulants and antithrombin-III].
    Baryshev BA; Selivanov EA; Kobilianskaia VI; Andozhskaia IV; Kurenkova VV; Papaian LP
    Vestn Khir Im I I Grek; 2000; 159(6):55-6. PubMed ID: 11209233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newer avenues in the monitoring of antithrombotic therapy: the role of automation.
    Walenga JM; Fareed J; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):346-54. PubMed ID: 6658465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assay of antithrombin III activity using chromogenic substrate (author's transl)].
    Koresawa S; Matsuda N; Ueda S
    Rinsho Byori; 1982 Jan; 30(1):54-8. PubMed ID: 7087231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.